BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8293615)

  • 1. [Pseudohyperkalemia in myotonic dystrophy].
    Nakazato Y; Shimazu K; Tamura N; Irino S; Hamaguchi K
    Rinsho Shinkeigaku; 1993 Oct; 33(10):1097-9. PubMed ID: 8293615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohyperkalemia secondary to postsplenectomy thrombocytosis.
    Johnson CM; Hughes KM
    Am Surg; 2001 Feb; 67(2):168-70. PubMed ID: 11243543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pseudohyperkalemia of erythrocyte origin. Passive increase of membrane permeability to potassium].
    Enet-Renou N; Mirouze J; Dagher G; Dupont M; Richard JL; Mimran A
    Pathol Biol (Paris); 1983 Sep; 31(7):583-8. PubMed ID: 6355987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemia in a neonate with congenital myotonic dystrophy.
    Miyata M; Kato N; Kubota M; Suzuki K; Yamazaki T
    Pediatr Int; 2009 Apr; 51(2):296-7. PubMed ID: 19379262
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude.
    Sevastos N; Theodossiades G; Efstathiou S; Papatheodoridis GV; Manesis E; Archimandritis AJ
    J Lab Clin Med; 2006 Mar; 147(3):139-44. PubMed ID: 16503244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients.
    Mahajan SK; Mangla M; Kishore K
    J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary sodium and potassium excretion following karate competitions.
    Afshar R; Sanavi S; Jalali Nadooshan MR
    Iran J Kidney Dis; 2009 Apr; 3(2):86-8. PubMed ID: 19395783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum carbonic anhydrase III in myotonic dystrophy.
    Mokuno K; Riku S; Matsuoka Y; Kato K
    Muscle Nerve; 1986; 9(3):257-60. PubMed ID: 3084971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spectrin extractabilities from erythrocyte membranes in patients with myotonic dystrophy].
    Li YS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Dec; 24(6):343-5, 383. PubMed ID: 1800059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohyperkalemia and extreme leukocytosis.
    Bellevue R; Dosik H; Spergel G; Gussoff BD
    J Lab Clin Med; 1975 Apr; 85(4):660-4. PubMed ID: 1120932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B; Meuthen I
    Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrolyte abnormalities and metabolic acidosis in two Duchenne muscular dystrophy patients with advanced congestive heart failure].
    Matsumura T; Saito T; Miyai I; Nozaki S; Kang J
    Rinsho Shinkeigaku; 2000 May; 40(5):439-45. PubMed ID: 11002725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pitfall in intraoperative electrolyte management for a patient with pseudohyperkalemia caused by thrombocytosis].
    Nomura M; Nakasuji M; Nakamura M; Imanaka N; Tanaka M; Kawashima H
    Masui; 2009 Oct; 58(10):1300-2. PubMed ID: 19860239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of myotonic dystrophy with electrolyte imbalance.
    Ko WJ; Kim KY; Kim SM; Hong SJ; Lee SH; Song R; Yang HI; Lee YA
    J Korean Med Sci; 2013 Jul; 28(7):1111-3. PubMed ID: 23853500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myotonic dystrophy with pseudohyperkalemia].
    Ota K; Shinto A; Nishioka T; Suehiro T; Hashimoto K
    Nihon Naika Gakkai Zasshi; 2003 Jul; 92(7):1331-2. PubMed ID: 12924282
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients.
    Siddiqi N; El Shahat O; Bokhari E; Roujouleh H; Hamid MH; Sheikh I; El-Sayed H; Saleh A; Seddik A
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum potassium influencing interacting drugs: risk-modifying strategies also needed at discontinuation.
    Uijtendaal EV; Zwart-van Rijkom JE; van Solinge WW; Egberts TC
    Ann Pharmacother; 2012 Feb; 46(2):176-82. PubMed ID: 22298604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial pseudohyperkalemia: a rare cause of hyperkalemia.
    Sugimoto T; Kume S; Osawa N; Nakazawa J; Koya D; Kashiwagi A
    Intern Med; 2005 Aug; 44(8):875-8. PubMed ID: 16157991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.